异烟肼效果丧失的原因是持续性，而非耐药性。 - Suppr

Persistence, not resistance, is the cause of loss of isoniazid effect.

作者信息

Wallis Robert S, Palaci Moises, Eisenach Kathleen

出版信息

J Infect Dis. 2007 Jun 15;195(12):1870-1; author reply 1872-3. doi: 10.1086/518044.

DOI:10.1086/518044

PMID:17492604

Abstract

摘要

相似文献

Persistence, not resistance, is the cause of loss of isoniazid effect.

J Infect Dis. 2007 Jun 15;195(12):1870-1; author reply 1872-3. doi: 10.1086/518044.

Isoniazid activity is terminated by bacterial persistence.

J Infect Dis. 2007 Jun 15;195(12):1871-2; author reply 1872-3. doi: 10.1086/518046.

Transmission of isoniazid-resistant tuberculosis.

J Infect Dis. 2004 Aug 1;190(3):650; author reply 650-1. doi: 10.1086/421283.

[Antibacterial effectiveness of long-acting isoniazid in the experiment].

Probl Tuberk. 1997(2):54-6.

Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).

Int J Antimicrob Agents. 2008 May;31(5):498-500. doi: 10.1016/j.ijantimicag.2008.01.008. Epub 2008 Mar 4.

Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.

J Infect Dis. 2007 Jan 15;195(2):194-201. doi: 10.1086/510247. Epub 2006 Dec 7.

Drug resistance in tuberculosis.

J Trop Pediatr. 2007 Jun;53(3):147-9. doi: 10.1093/tropej/fmm042. Epub 2007 May 25.

Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.

J Infect Dis. 2009 Oct 1;200(7):1136-43. doi: 10.1086/605605.

Genetic diversity of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Poland and assessed by spoligotyping.

J Clin Microbiol. 2008 Dec;46(12):4041-4. doi: 10.1128/JCM.01315-08. Epub 2008 Oct 1.

[Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].

Kekkaku. 2007 May;82(5):449-54.

引用本文的文献

Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.

PLoS One. 2022 Nov 17;17(11):e0277670. doi: 10.1371/journal.pone.0277670. eCollection 2022.

Digital Image Analysis of Heterogeneous Tuberculosis Pulmonary Pathology in Non-Clinical Animal Models using Deep Convolutional Neural Networks.

Sci Rep. 2020 Apr 8;10(1):6047. doi: 10.1038/s41598-020-62960-6.

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

J Antimicrob Chemother. 2018 Feb 1;73(2):437-447. doi: 10.1093/jac/dkx380.

The DosR regulon of M. tuberculosis and antibacterial tolerance.

Tuberculosis (Edinb). 2009 Jul;89(4):310-6. doi: 10.1016/j.tube.2009.06.001. Epub 2009 Jul 3.

Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.

Antimicrob Agents Chemother. 2009 Aug;53(8):3515-9. doi: 10.1128/AAC.00012-09. Epub 2009 Jun 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Persistence, not resistance, is the cause of loss of isoniazid effect.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献